Objectif
"Led by inventor Carmen Lamacchia, New Gluten World (NGW) is a company that aims at bringing on the market its
revolutionary proprietary technology that will be used in milling processes to detoxify gluten in wheat. The traditional
approach to celiac disease – that is, a “gluten free” diet or detoxified gluten with expensive enzymes – will be replaced by a
new, disruptive and cost-effective approach, where a natural and safe physic-chemical process modifies the toxic
component of gluten, while leaving its mechanical, nutritional, and sensorial properties. Celiac, intolerant, and glutensensitive
patients will have the chance of a new lifestyle, without suffering the “nutritional divide” with respect to healthy
individuals. The methodology stems from the advanced biotech research conducted at the University of Foggia and
addresses a grand social and economic challenge for Europe and for the world, where celiac patients are on average 1% of
the world population, while 30% has gluten-sensitivity, with figures increasing every year.
Thanks to a strong team, with industrial and technological expertise, NGW will enable milling companies (mostly SMEs) in
Europe and abroad to adopt the process technology and related know-how, thus reinforcing the well-known leadership of the
European agro-food industry in terms of quality, as opposed to intensive productions by other economic systems. The
market opportunity is huge, fenced by a patent extended in 104 countries. Such opportunity will be seized by NGW moving
from TRL #6 to TRL #8 and #9 in a 24-month time-span. Aiming to become the market leader for industrial processes in
detoxifying gluten in cereals for all markets (backed products, pasta, ice-creams, beer), NGW plans to reach a turnover of
over 100M€ by 2022, with an ambitious hiring plan of qualified workers in Europe.
NGW received the prestigious NutriAward (2015) and a manifestation of interest from a leading European venture capital
firm that will support its growth."
Champ scientifique
- natural sciencesbiological sciencesbiochemistrybiomoleculeslipids
- medical and health scienceshealth sciencesnutrition
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
- agricultural sciencesagriculture, forestry, and fisheriesagriculturegrains and oilseedscereals
- medical and health sciencesclinical medicinegastroenterology
Programme(s)
- H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme
- H2020-EU.3.2.4. - Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
- H2020-EU.3.2.1. - Sustainable agriculture and forestry
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.2.2. - Sustainable and competitive agri-food sector for a safe and healthy diet
Régime de financement
SME-2 - SME instrument phase 2Coordinateur
71121 FOGGIA FG
Italie
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.